All Articles

As Merck preps for its August 4th earnings call, investors look past Q2 numbers to see if a flurry of deals and pipeline wins can build a new empire.

The deal creates a $2.6 billion community bank, First Bank Midwest, aiming to blend tradition with scale. What does this mean for customers and the market?

As psychiatrist shortages worsen in PA & NJ, Author Health's tech-first model arrives for seniors. We look at the real-world impact behind the promises.

As Sobi prepares its Q2 2026 report, all eyes are on its booming immunology unit. After a stellar Q1, the key test is sustaining that momentum.

A new report shows buying American-made cars is more affordable than ever, but the brands leading the charge are not who you'd think. What does this signal?

With its acquisition of French startup QPerfect, BTQ isn't just buying software; it's buying a strategic R&D hub and a powerful emulation-first approach.

TI Marketing Solutions just launched TiForecast, a free tool that rejects AI hype, using 25 years of proprietary data to help marketers prove their value.

QXO's $17B TopBuild deal creates a new titan in building products, aiming for $50B in revenue. This is the signal in the noise of a major industry shift.

The acquisition of Severn Group is more than a purchase; it's a calculated move by Valmet to diversify beyond biomaterials and secure a critical role in global energy.

As AI fuels a new wave of cyber threats, Ridge Security adds defense veteran Ravinder Singh to its board, a strategic move in the race for autonomous security.

Copper Intelligence reports a high-grade find in the Congo, vital for the green economy. But can it navigate the long road from drill hole to reality?

An award for BIGO Ads highlights a seismic shift in advertising. We unpack how its AI platform is setting a new industry standard for accountable, ROI-driven growth.

The U.S. spirits market faces a prolonged slump, a new forecast shows. But beneath the negative numbers, data reveals a path to stability for savvy brands.

Millions of older Americans can now access the popular weight-loss drug Wegovy for a $50 copay, a temporary move that could reshape healthcare policy and the pharma market.

Metals Australia's Lac Carheil project reveals robust economics, aiming to become a key node in the EV battery supply chain with a fully integrated mine-to-anode strategy.

With over 90 million tons of textiles wasted annually, a new Pennsylvania lab is industrializing a technology to recycle polyester infinitely. Is this the end of waste?

New imaging data provides the first evidence that a drug-app combo for Parkinson's can induce physical changes in the brain, linking digital therapy to better outcomes.

Nuveen's landmark $546M deal for the SunZia project isn't just about money. It's a blueprint for funding the massive grid overhaul America desperately needs.

Oklo's Texas reactor just cleared a major safety hurdle. It's more than a win for one company; it's a test of a new, faster model for U.S. nuclear deployment.